Reports

Industry Research Reports

Global Personalized Psychiatry Market Research Report 2026

Global Personalized Psychiatry Market Research Report 2026

Industry: Service & Software

Published Date: 2026-01-14

Pages: 101 Pages

Report ld: 5661313

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

The global Personalized Psychiatry market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The North American market for Personalized Psychiatry is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Personalized Psychiatry is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Personalized Psychiatry in Mental Health Professionals is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Personalized Psychiatry include COMPASS Pathways, Mindstrong Health, Pear Therapeutics, Cogito, Kaia Health, Sooma, GenoMind, Empatica, Akili Interactive, Neuroverse, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Personalized Psychiatry market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Personalized Psychiatry. The Personalized Psychiatry market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Personalized Psychiatry market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Personalized Psychiatry manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

  • COMPASS Pathways
  • Mindstrong Health
  • Pear Therapeutics
  • Cogito
  • Kaia Health
  • Sooma
  • GenoMind
  • Empatica
  • Akili Interactive
  • Neuroverse

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Depression and Anxiety
  • Bipolar Disorder
  • Addiction
  • Other

Segment by Application

  • Mental Health Professionals
  • Patients
  • Healthcare Providers

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

marn_i1

Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.

marn_i1

Chapter 3: Provides a detailed view of the competitive landscape for Personalized Psychiatry companies, covering revenue share, development plans, and mergers and acquisitions.

marn_i1

Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.

marn_i1

Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

marn_i1

Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.

marn_i1

Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.

marn_i1

Chapter 12: Key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Personalized Psychiatry Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Depression and Anxiety

1.2.3 Bipolar Disorder

1.2.4 Addiction

1.2.5 Other

1.3 Market by Application

1.3.1 Global Personalized Psychiatry Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Mental Health Professionals

1.3.3 Patients

1.3.4 Healthcare Providers

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Global Growth Trends

2.1 Global Personalized Psychiatry Market Perspective (2021–2032)

2.2 Global Personalized Psychiatry Growth Trends by Region

2.2.1 Global Personalized Psychiatry Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Personalized Psychiatry Historic Market Size by Region (2021–2026)

2.2.3 Personalized Psychiatry Forecasted Market Size by Region (2027–2032)

2.3 Personalized Psychiatry Market Dynamics

2.3.1 Personalized Psychiatry Industry Trends

2.3.2 Personalized Psychiatry Market Drivers

2.3.3 Personalized Psychiatry Market Challenges

2.3.4 Personalized Psychiatry Market Restraints

muLu

3 Competition Landscape by Key Players

3.1 Global Top Personalized Psychiatry Players by Revenue

3.1.1 Global Top Personalized Psychiatry Players by Revenue (2021–2026)

3.1.2 Global Personalized Psychiatry Revenue Market Share by Players (2021–2026)

3.2 Global Top Personalized Psychiatry Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Personalized Psychiatry Revenue

3.4 Global Personalized Psychiatry Market Concentration Ratio

3.4.1 Global Personalized Psychiatry Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Personalized Psychiatry Revenue in 2025

3.5 Global Key Players of Personalized Psychiatry Head Offices and Areas Served

3.6 Global Key Players of Personalized Psychiatry, Products and Applications

3.7 Global Key Players of Personalized Psychiatry, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

muLu

4 Personalized Psychiatry Breakdown Data by Type

4.1 Global Personalized Psychiatry Historic Market Size by Type (2021–2026)

4.2 Global Personalized Psychiatry Forecasted Market Size by Type (2027–2032)

muLu

5 Personalized Psychiatry Breakdown Data by Application

5.1 Global Personalized Psychiatry Historic Market Size by Application (2021–2026)

5.2 Global Personalized Psychiatry Forecasted Market Size by Application (2027–2032)

muLu

6 North America

6.1 North America Personalized Psychiatry Market Size (2021–2032)

6.2 North America Personalized Psychiatry Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Personalized Psychiatry Market Size by Country (2021–2026)

6.4 North America Personalized Psychiatry Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

muLu

7 Europe

7.1 Europe Personalized Psychiatry Market Size (2021–2032)

7.2 Europe Personalized Psychiatry Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Personalized Psychiatry Market Size by Country (2021–2026)

7.4 Europe Personalized Psychiatry Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

muLu

8 Asia-Pacific

8.1 Asia-Pacific Personalized Psychiatry Market Size (2021–2032)

8.2 Asia-Pacific Personalized Psychiatry Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Personalized Psychiatry Market Size by Region (2021–2026)

8.4 Asia-Pacific Personalized Psychiatry Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

muLu

9 Latin America

9.1 Latin America Personalized Psychiatry Market Size (2021–2032)

9.2 Latin America Personalized Psychiatry Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Personalized Psychiatry Market Size by Country (2021–2026)

9.4 Latin America Personalized Psychiatry Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

muLu

10 Middle East & Africa

10.1 Middle East & Africa Personalized Psychiatry Market Size (2021–2032)

10.2 Middle East & Africa Personalized Psychiatry Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Personalized Psychiatry Market Size by Country (2021–2026)

10.4 Middle East & Africa Personalized Psychiatry Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

muLu

11 Key Players Profiles

11.1 COMPASS Pathways

11.1.1 COMPASS Pathways Company Details

11.1.2 COMPASS Pathways Business Overview

11.1.3 COMPASS Pathways Personalized Psychiatry Introduction

11.1.4 COMPASS Pathways Revenue in Personalized Psychiatry Business (2021–2026)

11.1.5 COMPASS Pathways Recent Development

11.2 Mindstrong Health

11.2.1 Mindstrong Health Company Details

11.2.2 Mindstrong Health Business Overview

11.2.3 Mindstrong Health Personalized Psychiatry Introduction

11.2.4 Mindstrong Health Revenue in Personalized Psychiatry Business (2021–2026)

11.2.5 Mindstrong Health Recent Development

11.3 Pear Therapeutics

11.3.1 Pear Therapeutics Company Details

11.3.2 Pear Therapeutics Business Overview

11.3.3 Pear Therapeutics Personalized Psychiatry Introduction

11.3.4 Pear Therapeutics Revenue in Personalized Psychiatry Business (2021–2026)

11.3.5 Pear Therapeutics Recent Development

11.4 Cogito

11.4.1 Cogito Company Details

11.4.2 Cogito Business Overview

11.4.3 Cogito Personalized Psychiatry Introduction

11.4.4 Cogito Revenue in Personalized Psychiatry Business (2021–2026)

11.4.5 Cogito Recent Development

11.5 Kaia Health

11.5.1 Kaia Health Company Details

11.5.2 Kaia Health Business Overview

11.5.3 Kaia Health Personalized Psychiatry Introduction

11.5.4 Kaia Health Revenue in Personalized Psychiatry Business (2021–2026)

11.5.5 Kaia Health Recent Development

11.6 Sooma

11.6.1 Sooma Company Details

11.6.2 Sooma Business Overview

11.6.3 Sooma Personalized Psychiatry Introduction

11.6.4 Sooma Revenue in Personalized Psychiatry Business (2021–2026)

11.6.5 Sooma Recent Development

11.7 GenoMind

11.7.1 GenoMind Company Details

11.7.2 GenoMind Business Overview

11.7.3 GenoMind Personalized Psychiatry Introduction

11.7.4 GenoMind Revenue in Personalized Psychiatry Business (2021–2026)

11.7.5 GenoMind Recent Development

11.8 Empatica

11.8.1 Empatica Company Details

11.8.2 Empatica Business Overview

11.8.3 Empatica Personalized Psychiatry Introduction

11.8.4 Empatica Revenue in Personalized Psychiatry Business (2021–2026)

11.8.5 Empatica Recent Development

11.9 Akili Interactive

11.9.1 Akili Interactive Company Details

11.9.2 Akili Interactive Business Overview

11.9.3 Akili Interactive Personalized Psychiatry Introduction

11.9.4 Akili Interactive Revenue in Personalized Psychiatry Business (2021–2026)

11.9.5 Akili Interactive Recent Development

11.10 Neuroverse

11.10.1 Neuroverse Company Details

11.10.2 Neuroverse Business Overview

11.10.3 Neuroverse Personalized Psychiatry Introduction

11.10.4 Neuroverse Revenue in Personalized Psychiatry Business (2021–2026)

11.10.5 Neuroverse Recent Development

muLu

12 Analyst's Viewpoints/Conclusions

muLu

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Personalized Psychiatry Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Depression and Anxiety
Table 3. Key Players of Bipolar Disorder
Table 4. Key Players of Addiction
Table 5. Key Players of Other
Table 6. Global Personalized Psychiatry Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Personalized Psychiatry Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Personalized Psychiatry Market Size by Region (US$ Million), 2021–2026
Table 9. Global Personalized Psychiatry Market Share by Region (2021–2026)
Table 10. Global Personalized Psychiatry Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Personalized Psychiatry Market Share by Region (2027–2032)
Table 12. Personalized Psychiatry Market Trends
Table 13. Personalized Psychiatry Market Drivers
Table 14. Personalized Psychiatry Market Challenges
Table 15. Personalized Psychiatry Market Restraints
Table 16. Global Personalized Psychiatry Revenue by Players (US$ Million), 2021–2026
Table 17. Global Personalized Psychiatry Market Share by Players (2021–2026)
Table 18. Global Top Personalized Psychiatry Players by Tier (Tier 1, Tier 2, and Tier 3), based on Personalized Psychiatry Revenue, 2025
Table 19. Ranking of Global Top Personalized Psychiatry Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Personalized Psychiatry Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Personalized Psychiatry, Headquarters and Area Served
Table 22. Global Key Players of Personalized Psychiatry, Products and Applications
Table 23. Global Key Players of Personalized Psychiatry, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Personalized Psychiatry Market Size by Type (US$ Million), 2021–2026
Table 26. Global Personalized Psychiatry Revenue Market Share by Type (2021–2026)
Table 27. Global Personalized Psychiatry Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Personalized Psychiatry Revenue Market Share by Type (2027–2032)
Table 29. Global Personalized Psychiatry Market Size by Application (US$ Million), 2021–2026
Table 30. Global Personalized Psychiatry Revenue Market Share by Application (2021–2026)
Table 31. Global Personalized Psychiatry Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Personalized Psychiatry Revenue Market Share by Application (2027–2032)
Table 33. North America Personalized Psychiatry Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Personalized Psychiatry Market Size by Country (US$ Million), 2021–2026
Table 35. North America Personalized Psychiatry Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Personalized Psychiatry Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Personalized Psychiatry Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Personalized Psychiatry Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Personalized Psychiatry Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Personalized Psychiatry Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Personalized Psychiatry Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Personalized Psychiatry Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Personalized Psychiatry Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Personalized Psychiatry Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Personalized Psychiatry Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Personalized Psychiatry Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Personalized Psychiatry Market Size by Country (US$ Million), 2027–2032
Table 48. COMPASS Pathways Company Details
Table 49. COMPASS Pathways Business Overview
Table 50. COMPASS Pathways Personalized Psychiatry Product
Table 51. COMPASS Pathways Revenue in Personalized Psychiatry Business (US$ Million), 2021–2026
Table 52. COMPASS Pathways Recent Development
Table 53. Mindstrong Health Company Details
Table 54. Mindstrong Health Business Overview
Table 55. Mindstrong Health Personalized Psychiatry Product
Table 56. Mindstrong Health Revenue in Personalized Psychiatry Business (US$ Million), 2021–2026
Table 57. Mindstrong Health Recent Development
Table 58. Pear Therapeutics Company Details
Table 59. Pear Therapeutics Business Overview
Table 60. Pear Therapeutics Personalized Psychiatry Product
Table 61. Pear Therapeutics Revenue in Personalized Psychiatry Business (US$ Million), 2021–2026
Table 62. Pear Therapeutics Recent Development
Table 63. Cogito Company Details
Table 64. Cogito Business Overview
Table 65. Cogito Personalized Psychiatry Product
Table 66. Cogito Revenue in Personalized Psychiatry Business (US$ Million), 2021–2026
Table 67. Cogito Recent Development
Table 68. Kaia Health Company Details
Table 69. Kaia Health Business Overview
Table 70. Kaia Health Personalized Psychiatry Product
Table 71. Kaia Health Revenue in Personalized Psychiatry Business (US$ Million), 2021–2026
Table 72. Kaia Health Recent Development
Table 73. Sooma Company Details
Table 74. Sooma Business Overview
Table 75. Sooma Personalized Psychiatry Product
Table 76. Sooma Revenue in Personalized Psychiatry Business (US$ Million), 2021–2026
Table 77. Sooma Recent Development
Table 78. GenoMind Company Details
Table 79. GenoMind Business Overview
Table 80. GenoMind Personalized Psychiatry Product
Table 81. GenoMind Revenue in Personalized Psychiatry Business (US$ Million), 2021–2026
Table 82. GenoMind Recent Development
Table 83. Empatica Company Details
Table 84. Empatica Business Overview
Table 85. Empatica Personalized Psychiatry Product
Table 86. Empatica Revenue in Personalized Psychiatry Business (US$ Million), 2021–2026
Table 87. Empatica Recent Development
Table 88. Akili Interactive Company Details
Table 89. Akili Interactive Business Overview
Table 90. Akili Interactive Personalized Psychiatry Product
Table 91. Akili Interactive Revenue in Personalized Psychiatry Business (US$ Million), 2021–2026
Table 92. Akili Interactive Recent Development
Table 93. Neuroverse Company Details
Table 94. Neuroverse Business Overview
Table 95. Neuroverse Personalized Psychiatry Product
Table 96. Neuroverse Revenue in Personalized Psychiatry Business (US$ Million), 2021–2026
Table 97. Neuroverse Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
muLu

List of Figures

Figure 1. Personalized Psychiatry Picture
Figure 2. Global Personalized Psychiatry Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Personalized Psychiatry Market Share by Type: 2025 vs 2032
Figure 4. Depression and Anxiety Features
Figure 5. Bipolar Disorder Features
Figure 6. Addiction Features
Figure 7. Other Features
Figure 8. Global Personalized Psychiatry Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Personalized Psychiatry Market Share by Application: 2025 vs 2032
Figure 10. Mental Health Professionals Case Studies
Figure 11. Patients Case Studies
Figure 12. Healthcare Providers Case Studies
Figure 13. Personalized Psychiatry Report Years Considered
Figure 14. Global Personalized Psychiatry Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Personalized Psychiatry Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Personalized Psychiatry Market Share by Region: 2025 vs 2032
Figure 17. Global Personalized Psychiatry Market Share by Players in 2025
Figure 18. Global Personalized Psychiatry Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Personalized Psychiatry Revenue in 2025
Figure 20. North America Personalized Psychiatry Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Personalized Psychiatry Market Share by Country (2021–2032)
Figure 22. United States Personalized Psychiatry Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Personalized Psychiatry Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Personalized Psychiatry Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Personalized Psychiatry Market Share by Country (2021–2032)
Figure 26. Germany Personalized Psychiatry Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Personalized Psychiatry Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Personalized Psychiatry Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Personalized Psychiatry Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Personalized Psychiatry Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Personalized Psychiatry Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Personalized Psychiatry Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Personalized Psychiatry Market Share by Region (2021–2032)
Figure 34. China Personalized Psychiatry Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Personalized Psychiatry Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Personalized Psychiatry Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Personalized Psychiatry Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Personalized Psychiatry Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Personalized Psychiatry Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Personalized Psychiatry Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Personalized Psychiatry Market Share by Country (2021–2032)
Figure 42. Mexico Personalized Psychiatry Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Personalized Psychiatry Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Personalized Psychiatry Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Personalized Psychiatry Market Share by Country (2021–2032)
Figure 46. Israel Personalized Psychiatry Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Personalized Psychiatry Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Personalized Psychiatry Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. COMPASS Pathways Revenue Growth Rate in Personalized Psychiatry Business (2021–2026)
Figure 50. Mindstrong Health Revenue Growth Rate in Personalized Psychiatry Business (2021–2026)
Figure 51. Pear Therapeutics Revenue Growth Rate in Personalized Psychiatry Business (2021–2026)
Figure 52. Cogito Revenue Growth Rate in Personalized Psychiatry Business (2021–2026)
Figure 53. Kaia Health Revenue Growth Rate in Personalized Psychiatry Business (2021–2026)
Figure 54. Sooma Revenue Growth Rate in Personalized Psychiatry Business (2021–2026)
Figure 55. GenoMind Revenue Growth Rate in Personalized Psychiatry Business (2021–2026)
Figure 56. Empatica Revenue Growth Rate in Personalized Psychiatry Business (2021–2026)
Figure 57. Akili Interactive Revenue Growth Rate in Personalized Psychiatry Business (2021–2026)
Figure 58. Neuroverse Revenue Growth Rate in Personalized Psychiatry Business (2021–2026)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Personalized Psychiatry market?zhanKai
The top companies in the global Personalized Psychiatry market are COMPASS Pathways、Mindstrong Health、Pear Therapeutics.
den_biaoTiZhungShi

Related Reports

Global Personalized Psychiatry Market Research Report 2026

Industry: Service & Software

Published Date: 2026-01-14

Pages: 101 Pages

Report ld: 5661313

CHOOSE LICENSE TYPE
tip

USD 2900.00

tip

USD 4350.00

tip

USD 5800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Offline

HITESH

English, Hindi

Online

TANG XIN

Japanese,English

Online

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Online

YUJIE TIAN

Chinese, English

Online

DAMON

Chinese, English

Online

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now